# The Effects of Wuniuzao Green Tea on Mice With High‐Fat Diet‐Induced Liver Steatosis

**Authors:** Yiwei Yuan, Jiangcheng Ye, Mingxiu Gong, Yifan Zhang, Qianqian Xu, Jin Zhao

PMC · DOI: 10.1002/fsn3.70505 · Food Science & Nutrition · 2025-07-03

## TL;DR

Wuniuzao green tea helps reduce liver fat and improve gut health in mice on a high-fat diet, suggesting it could be a useful dietary supplement.

## Contribution

This study is the first to report the effects of Wuniuzao green tea on liver steatosis and gut microbiota in mice.

## Key findings

- WGT reduced body weight, lipid accumulation, and serum lipid levels in mice on a high-fat diet.
- WGT improved liver function, glucose tolerance, and inhibited hepatic steatosis.
- WGT increased gut microbiota diversity and modulated the Firmicutes to Bacteroidetes ratio.

## Abstract

Wuniuzao is a famous Chinese tea with a history of more than 300 years. It is suitable for bulk production with excellent quality. Most current studies have focused on the cultivation, aroma compounds, and antioxidant capacity of Wuniuzao tea. However, the biological effects of Wuniuzao green tea water (WGT) extract on the prevention of high‐fat diet (HFD)‐induced liver steatosis and modulation of the intestinal microbiota have not yet been reported. This study was conducted to fill these gaps. Mice were divided into four groups and fed a normal diet, HFD, HFD + atorvastatin (10 mg/kg, positive control), and HFD + WGT (300 mg/kg), respectively. Nine‐week administration of WGT reduced body weight, lipid accumulation, and serum lipid levels in HFD‐fed mice. Liver function and serum glucose tolerance were improved, and hepatic steatosis was inhibited in the WGT group. Moreover, WGT treatment activated the AMPK signaling pathway, suggesting a mechanism for its effect on hepatic steatosis. WGT supplementation also increased intestinal microbiota diversity and modulated the ratio of Firmicutes to Bacteroidetes. WGT significantly alleviated HFD‐induced liver steatosis and modulated HFD‐induced intestinal microbial dysbiosis, suggesting its potential as a dietary supplement against HFD‐induced obesity and associated liver steatosis.

WGT can significantly alleviate HFD‐induced liver steatosis, regulate intestinal microbial disorders, and serve as a dietary supplement to tackle obesity in mice.

## Linked entities

- **Chemicals:** atorvastatin (PubChem CID 60823), WGT (PubChem CID 718227)
- **Diseases:** obesity (MONDO:0011122)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** obesity (MESH:D009765), Liver Steatosis (MESH:D005234)
- **Chemicals:** WGT (-), lipid (MESH:D008055), glucose (MESH:D005947), Fat (MESH:D005223)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12224049/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12224049/full.md

## References

69 references — full list in the complete paper: https://tomesphere.com/paper/PMC12224049/full.md

---
Source: https://tomesphere.com/paper/PMC12224049